Financials

  • Market Capitalization 1.44 B
  • Employee 7
  • Founded 2011
  • CEO N/A
  • Website www.damoratx.com
  • Headquarter Delaware, United States
  • FIGI BBG00XMLGWC5
  • Industry N/A
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2145
TRLV
Trulieve Cannabis Corp.
8.68 USD-7.17%-21.38%-21.02%-26.38%1.48 B USD
2162
SIND
Sinda Ltd.
9.0900 USD-18.26%-25.64%-19.84%-16.53%1.44 B USD
2166
PONY
Pony AI Inc. American Depositary Shares
3.31 USD-5.97%-23.56%-31.04%-71.73%1.44 B USD
2169
KLRA
Kailera Therapeutics, Inc. Common Stock
11.02 USD-4.84%-14.64%-13.91%-57.62%1.43 B USD

Frequently asked questions about Damora Therapeutics, Inc. Ordinary Shares

What is the Damora Therapeutics, Inc. Ordinary Shares stock price today?

The current price of Damora Therapeutics, Inc. Ordinary Shares (DMRA) is 23.22. Over the past 24 hours, the stock has changed by -4.44%. Follow the DMRA chart for real-time price dynamics.

What is the stock ticker of Damora Therapeutics, Inc. Ordinary Shares?

Damora Therapeutics, Inc. Ordinary Shares trades under the ticker DMRA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Damora Therapeutics, Inc. Ordinary Shares stock going up?

DMRA has changed by +6.12% over the last week, +8.25% over the last month, and -17.07% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Damora Therapeutics, Inc. Ordinary Shares?

Damora Therapeutics, Inc. Ordinary Shares currently has a market capitalization of 1.44 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Damora Therapeutics, Inc. Ordinary Shares earnings last quarter?

Last quarter, Damora Therapeutics, Inc. Ordinary Shares reported earnings of -0.4 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Damora Therapeutics, Inc. Ordinary Shares revenue for the last quarter?

Damora Therapeutics, Inc. Ordinary Shares reported quarterly revenue of 4.12 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Damora Therapeutics, Inc. Ordinary Shares net income for the last quarter?

Damora Therapeutics, Inc. Ordinary Shares reported net income of -31.99 M for the last quarter. The previous quarter showed -31.17 M, which means net income changed by -2.62%.

How many employees does Damora Therapeutics, Inc. Ordinary Shares have?

As of the latest available data, Damora Therapeutics, Inc. Ordinary Shares has 7 employees. Workforce size can provide additional context about the company's scale and operations.

What is Damora Therapeutics, Inc. Ordinary Shares EBITDA?

Damora Therapeutics, Inc. Ordinary Shares EBITDA is -32.66 M, and its EBITDA margin is -792.38%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Damora Therapeutics, Inc. Ordinary Shares stock?

You can buy Damora Therapeutics, Inc. Ordinary Shares (DMRA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Damora Therapeutics, Inc. Ordinary Shares stock?

Investing in Damora Therapeutics, Inc. Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DMRA chart and related analysis on metatrader.com as part of your research.